SPECT molecular imaging in Parkinson's disease

Citations of this article
Mendeley users who have this article in their library.


Parkinson's disease (PD) is a common disorder, and the diagnosis of Parkinson's disease is clinical and relies on the presence of characteristic motor symptoms. The accuracy of the clinical diagnosis of PD is still limited. Functional neuroimaging using SPECT technique is helpful in patients with first signs of parkinsonism. The changes detected may reflect the disease process itself and/or compensatory responses to the disease, or they may arise in association with disease- and/or treatment-related complications. This paper addresses the value of SPECT in early differential diagnosis of PD and its potential as a sensitive tool to assess the pathophysiology and progression, as well as the therapeutic efficacy of PD. Copyright © 2012 Ling Wang et al.




Wang, L., Zhang, Q., Li, H., & Zhang, H. (2012). SPECT molecular imaging in Parkinson’s disease. Journal of Biomedicine and Biotechnology. https://doi.org/10.1155/2012/412486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free